More Pandemic Corruption: Refusal to Fully Recognize Natural Immunity
Joel S. Hirschhorn The newest wrinkle on pandemic corruption is how most of the medical and public health establishment refuses to accept natural immunity, obtained…
$250,000 reward for Fauci whistleblowers
Here is your big chance to help yourself and help the world at the same time. Chris Martenson’s Fauci takedown videos (episodes 7,8,9) are pretty compelling.…
There’s No Need to Vaccinate Healthy Kids, According to MedPage Today Editor
At least some contributing Op-Ed authors at TrialSite have considerable concerns involving the exposure of the investigational COVID-19 vaccines to children. Apparently, a growing number of…
Rockefeller University & Bristol Myers Squibb Developed mAbs Embraced by ACTG for ACTIV-2 COVID-19 Trial
The world’s largest global HIV research network has embraced two new monoclonal antibodies as part of the COVID-19 outpatient study sponsored by the National Institutes…
Aarhus University Hospital Led Study Indicates COVID-19 Patients Have Robust Natural Immune Response Regardless of Disease Severity
A group of researchers out of Denmark led by Aarhus University Hospital’s infectious disease department conducted a study involving 203 COVID-19 infected patients between the…
Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors Targeting Hematological Cancers
Kurome Therapeutics, a preclinical stage company based in Cincinnati, OH, announced the closing of a $15 million Series A financing. The round was co-led by…
Stellanova Therapeutics Closes $15.5 Million Series A Financing
Houston, TX- based Stellanova Therapeutics announced the closing of a $15.5 million Series A financing led by Sporos Bioventures, LLC. Proceeds will support development of antibody…
Amyl Therapeutics Raises $22.3M in Series A Funding to Target Rare Protein Misfolding Diseases and Neurodegenerative Diseases
Amyl Therapeutics has closed $22.3 million in Series A financing, led by Belgium-based Noshaq, with participation from Merieux Participations, Sambrinvest, and other private investors. Additionally,…
Kojin Therapeutics Launches with $60M Series A to Develop Drugs Based on Cell State Biology for Difficult-to-Treat Diseases
Cambridge, MA- based Kojin Therapeutics launched with a $60 million Series A led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital.…
Cleveland Clinic Study Indicates Healthcare Workers Infected with COVID-19 Unlikely to Benefit from Vaccination
Recent observational research at Cleveland Clinic involving employees found that once they are infected with SARS-CoV-2, the virus behind COVID-19, they are not reinfected with the…